Simulations Plus, Inc. announced that it has entered into a distribution agreement with Mosim to distribute MonolixSuite™, the Lixoft division’s pharmacokinetic/pharmacodynamic (PK/PD) modeling platform, in China. This distribution agreement with Mosim for MonolixSuite will complement the existing arrangement between Simulations Plus and PharmoGo Co., Limited, the China-based distributor for the Company’s software products, including GastroPlus® and ADMET Predictor®, thereby expanding the Company’s reach across discovery, pre-clinical and clinical research and development within China’s pharmaceutical industry.